with thyroid function in relation to exposure to endocrine disruptors chemicals among which perfluorinated compounds (PFCs) are considered a priority research issue.Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) are widely diffused since used in the productions of polymers, additives, adhesives, cosmetics,insecticides and many other uses. PFCs are characterized by a high potential to bioaccumulate, by binding proteins, aspect that allows transmission of contaminationthrough food chains and retention in the body, once assumed.Objective and hypotheses: Aim of this study is to assess PFCs concentrations in children with autoimmune endocrine diseases such as type 1 diabetes (T1DM) andthyroiditis (Tr).Methods: Sixtythreechildren were recruited and subdivided in the following three groups: A) twentyfivesubjects (6.11±3.33 yr.) with T1DM, B) nineteen subjects(6.57±2.69 yr.) with Tr, and C) nineteen healthy controls matched for age and gender. Blood samples to assay PFCs were collected and stored few day after T1DM or Trwere diagnosed. PFOS and PFOA have been extracted following an ionpairingextraction procedure and determined by HPLCESIMS.Nonparametric statistical analysiswas performed.Results: PFOS concentrations resulted significantly higher in both T1DM and Tr patients respect to controls (1.53±1.50 and 1.21±1.57 vs. 0.55±0.15 ng/ml, respectively;χ2 =8.12; KruskalWallistest=14.5; p=0.017) (Figure). No difference was found in PFOA levels.Conclusions:

High levels of serum perfluorinated compounds in children with endocrine autoimmune disease / Iughetti, Lorenzo; C., Guerranti; Predieri, Barbara; Bonetti, Annalisa; S., Madeo; Patianna, VIVIANA DORA; S., Luisi; E. L., Fanello; G., Perra; S., Focardi. - In: HORMONE RESEARCH IN PAEDIATRICS. - ISSN 1663-2818. - STAMPA. - 76 (S2):(2011), pp. 57-57. (Intervento presentato al convegno 50th Annual ESPE Meeting tenutosi a GLASGOW nel 22-25/09/2011).

High levels of serum perfluorinated compounds in children with endocrine autoimmune disease.

IUGHETTI, Lorenzo;PREDIERI, Barbara;BONETTI, Annalisa;PATIANNA, VIVIANA DORA;G. Perra;
2011

Abstract

with thyroid function in relation to exposure to endocrine disruptors chemicals among which perfluorinated compounds (PFCs) are considered a priority research issue.Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) are widely diffused since used in the productions of polymers, additives, adhesives, cosmetics,insecticides and many other uses. PFCs are characterized by a high potential to bioaccumulate, by binding proteins, aspect that allows transmission of contaminationthrough food chains and retention in the body, once assumed.Objective and hypotheses: Aim of this study is to assess PFCs concentrations in children with autoimmune endocrine diseases such as type 1 diabetes (T1DM) andthyroiditis (Tr).Methods: Sixtythreechildren were recruited and subdivided in the following three groups: A) twentyfivesubjects (6.11±3.33 yr.) with T1DM, B) nineteen subjects(6.57±2.69 yr.) with Tr, and C) nineteen healthy controls matched for age and gender. Blood samples to assay PFCs were collected and stored few day after T1DM or Trwere diagnosed. PFOS and PFOA have been extracted following an ionpairingextraction procedure and determined by HPLCESIMS.Nonparametric statistical analysiswas performed.Results: PFOS concentrations resulted significantly higher in both T1DM and Tr patients respect to controls (1.53±1.50 and 1.21±1.57 vs. 0.55±0.15 ng/ml, respectively;χ2 =8.12; KruskalWallistest=14.5; p=0.017) (Figure). No difference was found in PFOA levels.Conclusions:
2011
76 (S2)
57
57
Iughetti, Lorenzo; C., Guerranti; Predieri, Barbara; Bonetti, Annalisa; S., Madeo; Patianna, VIVIANA DORA; S., Luisi; E. L., Fanello; G., Perra; S., Focardi
High levels of serum perfluorinated compounds in children with endocrine autoimmune disease / Iughetti, Lorenzo; C., Guerranti; Predieri, Barbara; Bonetti, Annalisa; S., Madeo; Patianna, VIVIANA DORA; S., Luisi; E. L., Fanello; G., Perra; S., Focardi. - In: HORMONE RESEARCH IN PAEDIATRICS. - ISSN 1663-2818. - STAMPA. - 76 (S2):(2011), pp. 57-57. (Intervento presentato al convegno 50th Annual ESPE Meeting tenutosi a GLASGOW nel 22-25/09/2011).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/739308
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact